1. Home
  2. GBIO vs SYPR Comparison

GBIO vs SYPR Comparison

Compare GBIO & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • SYPR
  • Stock Information
  • Founded
  • GBIO 2016
  • SYPR 1997
  • Country
  • GBIO United States
  • SYPR United States
  • Employees
  • GBIO N/A
  • SYPR N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • SYPR Industrial Machinery/Components
  • Sector
  • GBIO Health Care
  • SYPR Industrials
  • Exchange
  • GBIO Nasdaq
  • SYPR Nasdaq
  • Market Cap
  • GBIO 41.2M
  • SYPR 47.7M
  • IPO Year
  • GBIO 2020
  • SYPR 1994
  • Fundamental
  • Price
  • GBIO $5.19
  • SYPR $2.19
  • Analyst Decision
  • GBIO Buy
  • SYPR
  • Analyst Count
  • GBIO 4
  • SYPR 0
  • Target Price
  • GBIO $10.67
  • SYPR N/A
  • AVG Volume (30 Days)
  • GBIO 66.5K
  • SYPR 25.0K
  • Earning Date
  • GBIO 11-07-2025
  • SYPR 11-10-2025
  • Dividend Yield
  • GBIO N/A
  • SYPR N/A
  • EPS Growth
  • GBIO N/A
  • SYPR N/A
  • EPS
  • GBIO N/A
  • SYPR N/A
  • Revenue
  • GBIO $21,230,000.00
  • SYPR $130,040,000.00
  • Revenue This Year
  • GBIO N/A
  • SYPR N/A
  • Revenue Next Year
  • GBIO N/A
  • SYPR N/A
  • P/E Ratio
  • GBIO N/A
  • SYPR N/A
  • Revenue Growth
  • GBIO 61.15
  • SYPR N/A
  • 52 Week Low
  • GBIO $3.00
  • SYPR $1.31
  • 52 Week High
  • GBIO $25.70
  • SYPR $3.72
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 31.12
  • SYPR 55.57
  • Support Level
  • GBIO $5.10
  • SYPR $1.93
  • Resistance Level
  • GBIO $6.47
  • SYPR $2.15
  • Average True Range (ATR)
  • GBIO 0.26
  • SYPR 0.09
  • MACD
  • GBIO -0.14
  • SYPR 0.00
  • Stochastic Oscillator
  • GBIO 6.57
  • SYPR 100.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

Share on Social Networks: